Cancerous brain tumor cells may be at ‘critical point’ between order and disorder

Large-scale coordination of brain tumor behavior may allow tumor cells to resist better against therapies such as chemotherapy and radiation, researchers say

2:00 PM

Author | Noah Fromson

cancer cell
Justine Ross, Jacob Dwyer, Michigan Medicine

Glioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clinical trials, the tumor’s survival rate has remained stagnant.

For years, scientists understood the cells in these tumors as static and relatively fixed. But recent studies have uncovered that glioblastomas contain active cells moving in complex patterns known as “oncostreams”, which determine how aggressively the tumors grow.

Research led by Michigan Medicine and the University of Michigan, published in Science Advances, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.

SEE ALSO: Dynamic cells linked to brain tumor growth and recurrence (michiganmedicine.org)

“Many people imagine that tumors are made up of different, unconnected cells that invade the normal brain, but we are seeing patterns of organization that show the tumor working almost like a single entity,” said senior author Pedro Lowenstein, M.D., Ph.D., Richard C. Schneider Collegiate Professor of Neurosurgery at U-M Medical School and member of the U-M Health Rogel Cancer Center.

“This large-scale coordination of brain tumor behavior may allow tumor cells to resist better against therapies, such as chemotherapy and radiotherapy. Disrupting the large-scale organization of brain tumors may result in more powerful ways to treat and one day eliminate brain tumors.”

The research team used time-resolved tracking of individual glioblastoma cells and investigated their movement by implanting genetically engineered NPA-green, fluorescent cells into the brains of mice.

Results of the study of the movement of glioma cells initially suggested that the cells may be moving independently.

But through examining cell populations of different sizes, researchers found correlated fluctuations across distances many times the size of a single cell, to close to the size of the whole tumor preparation for imaging tumor movement under a microscope.

“Our results indicate that beneath a weakly ordered façade, brain tumor assemblies actually have some form of collective behavior on scales of millimeters or more,” said first author Kevin Wood, Ph.D., an associate professor in the Departments of Physics and Biophysics at U-M.

“The work demonstrates that collaboration between biologists and biophycisists working at the frontiers of neuro-oncology and physics can provide new avenues for understanding and potentially treating so far incurable cancers.”

Researchers say more research is needed before any clinical implications are determined.

Additional authors include Andrea Comba, Ph.D., of University of Michigan, Sebastien Motsch, Arizona State University Ph.D., and Tomás S. Grigera, Ph.D., of The University of La Plata, Argentina.

This work was supported by the NIH/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grants R01-NS105556, R01-NS122536, R01-NS124167, and R21-NS123879-01; NIH/NINDS grants R01NS122234, RO1NS127378, and NIH/NCI R01-CA243916 to P.R.L.; Rogel Cancer Center, the Department of Neurosurgery; the Pediatric Brain Tumor Foundation, Leah’s Happy Hearts Foundation (G013908), Ian’s Friends Foundation (IFF) (G024230), Chad Tough Foundation (G023419), and Smiles for Sophie Forever Foundation to P.R.L.; NIH R35GM124875 to K.W.; Health and Human Services, NIH, UL1 TR002240 to Michigan Institute for Clinical and Health Research (MICHR), Postdoctoral Translational Scholars Program (PTSP), Project F049768 to A.C.; and the NSF DMS-2206330 to S.M.

Paper cited: “Scale-free correlations and potential criticality in weakly ordered populations of brain cancer cells,” Scientific Advances. DOI: 10.1126/sciadv.adf7170


More Articles About: Cancer: Cancer Types Brain Cancer Cancer Research Cancer Surgery Tumors and Lumps Neurosurgery & Neurological Procedures Neurological Disorders Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories blue purple cell dots on white background all over in different patterns
Health Lab
Research finds possible therapies to target oncogenic transcription factors in multiple cancer types
A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
iv chemo bags
Health Lab
Drug-chemo combo increases cancer treatment efficacy
A study finds giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer
Michigan State University logo and University of Michigan logo side by side above new neuro care network initiative
News Release
U-M Health, MSU Health Care create historic agreement to enhance neuroscience care for mid-Michigan
University of Michigan Health and MSU Health Care are entering into a joint operating agreement to provide neurosurgery and neurology care to the people of mid-Michigan
close up photo of yellow pills lined up on a bright blue matt
Health Lab
New drug candidate blocks resistance to cancer therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.
two women, one older one younger, looking concerned listening to a provider across from them with back to camera
Health Lab
Many breast cancer survivors don't receive genetic testing, despite being eligible
As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.
10 year old in wheelchair at hospital, also posing on physical therapy mats.
Health Lab
10-year-old works to regain independence after rare brain hemorrhage
A young girl works with physical therapists and other specialists in two unique clinics to regain strength again after a rare brain hemorrhage.